Přihlášení

 
CzMA JEP: Current issue
Archive
Subscription
For authors and reviewers

DIACEREIN (ARTRODAR ® ) - A NEW DRUG FROM THE SYSADOA GROUPIN THE TREATMENT OF OSTEOARTHRITIS

Authors: Pavelková A., Pavelka K.

Authors - sphere of activity: Revmatologický ústav, Praha

Article: Čes. Revmatol., , 2000, No. 2, p. 57-61.
Number of articles displayed: 3552x

Specialization: Dermatology & STDs Paediatric rheumatology Rheumatology

Summary


The authors present the pharmacological profile and an account of the clinical effectiveness ofdiacerein. It is a preparation which inhibits above all the production and activity of interleukin-1(IL-1) as well as other cytokines and catabolic enzymes which participate in the degradation ofcartilage in osteoarthritis (OA). The implemented clinical studies provide evidence of its effective-ness on pain and function in patients with hip and knee osteoarthritis. As to the character of itseffect diacerein belongs to so-called SYSADOA, symptomatically slow acting drugs in OA. The onsetof its effect is as compared with NSA retarded, the onset being after 2-4 weeks. Then its effectivenessis identical as that of NSA. While after discontinuation of NSA treatment the patients exacerbatesas a rule, after termination of diacerein treatment the favourable effect persists for another 2-3months. A recently completed study revealed that in addition to the purely symptomatic effect afterlong-term diacerein treatment the progression of OA is perhaps slower. Thus a drug potentiallymodifying the structure is involved. The assembled results will have to be confirmed in furtherinvestigations. Diacerein is a safe preparation, the main undesirable effect is diarrhoea whichhowever occurs only at the onset of treatment and as a rule does not lead to discontinuation oftherapy.

Key words:
osteoarthritis, diacerein, therapy, SYSADOA

 

Rate article

Rate article:     2,9/5, evaluated 33x
 
 

K. Kupka, C. Dostál, V. Peterová, M. Olejárová, J. Obenberger, Z. Seidl 4
Česká revmatologie

Recidivující (relabující) polychondritis

M. Kučera, J. Racek, K. Trnavský, J. Herlík 4
Česká revmatologie

Postižení mozku u nemocných se SLE (popis 2 případů)

V. Peterová, C. Dostál, Z. Seidl, J. Daneš, J. Obenberger, J. Faber, P. Adam, M. Olejárová, T. Viták 1
Česká revmatologie

Proteíny tepelného šoku – dôležitá súčasť imunitnej odpovede

Remáková M., Novota P.
Česká revmatologie

Masivní gastrointestinální krvácení u pacientky s Wegenerovou granulomatózou – kazuistika

Frausová D., Brejníková M., Šafránková H., Hrušková Z., Tesař V.
Česká revmatologie

Hallux valgus u pacientů s revmatoidní artritidou – současné možnosti operační terapie

Popelka S, Vavřík P, Hromádka R, Barták V, Bek J, Sosna A
Česká revmatologie